Description: Omega Alpha SPAC, sponsored by an affiliate of Omega Fund VI, L.P., is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. Omega Alpha SPAC expects that its focus will be on the biotechnology sector in developed countries including, but not limited to, the United States and countries in Europe.
888 Boylston Street
Boston,
MA
02199
United States
Phone:
857 268 4429
Officers
| Name | Title |
|---|---|
| Dr. Otello Stampacchia Ph.D. | Chairman & CEO |
| Ms. Michelle Doig | Pres & Director |
| Mr. Francesco L. Draetta C.A.I.A., C.F.A., CFA, F.R.M. | Chief Financial Officer |
| Dr. Vincent Ossipow C.F.A., CFA, Ph.D. | Chief Scientific Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3306 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-01-07 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |